Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.

Song-Yang ZhangMing-Jiang XuXian Wang

Published in: British journal of pharmacology (2017)

This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.

Keyphrases

cardiovascular disease
type diabetes
emergency department
benign prostatic hyperplasia
metabolic syndrome
cardiovascular events
smoking cessation